Welcoming everyone with an interest in head and neck cancer of unknown primary to participate in my PhD defence in Aarhus, on the 31st of May.

Læge og sygeplejerske forlader regeringens Udvalg for en mere værdig død - yderst tankevækkende! - efterlader indtryk af, at resultatet fra udvalget SKAL være en model for aktiv dødshjælp. Respekt og forståelse for beslutningen #sundpol #dkpol kristeligt-dagblad.dk/danmark/medlem…

Døden skal være værdig og bør ikke politiseres! Min god ven og fantastiske kollega @EmmaHelledie har integritet nok til at vide, at udvalget om værdig død er politisk bestillingsarbejde af regeringen, og handler mere om ambitioner end kvalitet #sundpol dr.dk/nyheder/indlan…

We’ve been waiting for this one!! RELATIVITY-048 (ipi 1Q8wi+nivo+rela) presented by Paolo A. Ascierto! ORR 52% by BICR. Clinical benefit rate 76%. 50% discontinuation due to toxicity. #ASCO24 #Melanoma OncoAlert

The Melanoma Research Foundation joins the melanoma community in expressing our profound condolences on the recent passing of Jeffrey S. Weber, MD, PhD. Dr. Weber was an internationally recognized and trailblazing pioneer in cancer immune therapy and melanoma and made countless

Cardiotoxicity of Immune Checkpoint Inhibitors jamanetwork.com/journals/jamao…

Looking forward to #ESMO24 🙂

Bravo! Chiara Ciccarese - beautiful presentation. Congrats to you, Roberto Iacovelli & the stellar team on intriguing data - a hugely important contribution to the emerging data on #microbiome modulation. Looking fwd to seeing next steps! #ESMO24

#ESMO24: Questions remain on optimal #AdjuvantTherapy for advanced #melanoma. OS trial data are not yet available & #RealWorld data suggest that surrogate endpoints may not translate into OS benefit in clinical practice Teresa Amaral, MD, PhD #ESMODailyReporter 📌ow.ly/51Cs50TnILV

Hildur Helgadottir presents out Swedish data showing no OS benefit with adjuvant immunotherapy for stage III melanoma. #ESMO24

This is one of the greatest achievements in the history of cancer treatment. #melanoma #immunotherapy #esmo24 #cure

Man bør anerkende, at der er områder, hvor mænd er særligt udsatte. Ligestillingen halter, når det for eksempel kommer til mænds mentale sundhed. Det har jeg skrevet om sammen med Samira Nawa og en række aktører på området. #dkpol #sundpol socialmonitor.dk/debat/art10200…

I don't think I've ever worked this hard on anything in my career. The initial work for this study started back in 2016. Despite legal challenges with digital health data and the COVID-19 lockdown, we succeeded with a tremendous collaboratory effort in this Danish national RCT 🙂

Great presentation at the annual Danish Melanoma Scientific Meeting by Roger Olofsson Bagge about present and future surgical treatment of advanced melanoma

Danish Melanoma Lifetime Achievement Award to Lars Bastholt - Danish Metastatic Melanoma Database Christina Ruhlmann Marco Donia Rasmus Blechingberg Friis oncodaily.com/blog/danish-me… #Cancer #OncoDaily #MedEd #MedX #MedNews #Medicine #Oncology #DAMMED

Editorial comments on the ProWide study. I agree that clinical use of ePROs offers several important benefits beyond overall survival. #lungcancer ascopubs.org/doi/10.1200/OP…

Find me on bsky.app/profile/rbfrii… #twitterisdead